Literature DB >> 11441220

A comparison of the costs and survival of hospital-admitted stroke patients across Europe.

R Grieve1, J Hutton, A Bhalla, D Rastenytë, D Ryglewicz, C Sarti, M Lamassa, M Giroud, R Dundas, C D Wolfe.   

Abstract

BACKGROUND AND
PURPOSE: Policy makers require evidence on the costs and outcomes of different ways of organizing stroke care. This study compared the costs and survival of different ways of providing stroke care.
METHODS: Hospitalized stroke patients from 13 European centers were included, with demographic, case-mix, and resource use variables measured for each patient. Unit costs were collected and converted into US dollars using the purchasing power parity (PPP) index. Cox and linear regression analyses were used to compare survival and costs between the centers adjusting for case mix.
RESULTS: A total of 1847 patients were included in the study. After case-mix adjustment, the mean predicted costs ranged from $466 [95% CI 181 to 751] in Riga (Latvia) to $8512 [7696 to 9328] in Copenhagen (Denmark), which reflected differences in unit costs, and resource use. The mean length of hospitalization ranged from 8.3 days in Menorca (Spain) to 36.8 days in Turku B (Finland). In the 3 Finnish centers at least 80% of patients were admitted to wards providing organized stroke care, which was not provided at the centers in Almada (Portugal), Menorca, or Riga. Patients in Turku A and Turku B were less likely to die than those in Riga, Warsaw (Poland), or Menorca. The adjusted hazard ratios were 0.18 [0.10 to 0.32] for Turku A, 0.18 [0.10 to 0.32] for Turku B, 0.68 [0.48 to 0.96] for Warsaw, and 0.56 [0.33 to 0.96] for Menorca, all compared with Riga.
CONCLUSIONS: The cost of stroke care varies across Europe because of differences in unit costs, and resource use. Further research is needed to assess which ways of organizing stroke care are the most cost-effective.

Entities:  

Mesh:

Year:  2001        PMID: 11441220     DOI: 10.1161/01.str.32.7.1684

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  22 in total

1.  Variations in care and outcome in the first year after stroke: a Western and Central European perspective.

Authors:  H Markus
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-12       Impact factor: 10.154

2.  Anticoagulation for stroke prevention: high effectiveness, more cost benefit?

Authors:  Eduard Shantsila; Timothy Watson; Gregory Y H Lip
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  Improving the outcome of stroke.

Authors:  Hugh Markus
Journal:  BMJ       Date:  2007-08-25

Review 4.  A literature review of indirect costs associated with stroke.

Authors:  Heesoo Joo; Mary G George; Jing Fang; Guijing Wang
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-06-21       Impact factor: 2.136

Review 5.  'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data.

Authors:  Andrea Manca; Andrew R Willan
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 6.  A benefit-risk assessment of agents used in the secondary prevention of stroke.

Authors:  Ronald S MacWalter; Colin P Shirley
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

7.  Economic burden of stroke: a systematic review on post-stroke care.

Authors:  S Rajsic; H Gothe; H H Borba; G Sroczynski; J Vujicic; T Toell; Uwe Siebert
Journal:  Eur J Health Econ       Date:  2018-06-16

8.  Facilities available in French hospitals treating acute stroke patients: comparison with 24 other European countries.

Authors:  D Leys; C Cordonnier; S Debette; W Hacke; E B Ringelstein; M Giroud; J L Mas; M Kaste
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

9.  The cost of treating advanced non-small cell lung cancer: estimates from the chinese experience.

Authors:  Xiaohui Zeng; Jonathan Karnon; Siying Wang; Bin Wu; Xiaomin Wan; Liubao Peng
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

10.  Evaluating the effects of variation in clinical practice: a risk adjusted cost-effectiveness (RAC-E) analysis of acute stroke services.

Authors:  Clarabelle Pham; Orla Caffrey; David Ben-Tovim; Paul Hakendorf; Maria Crotty; Jonathan Karnon
Journal:  BMC Health Serv Res       Date:  2012-08-21       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.